vs
Diversified Energy Co（DEC）与Indivior Pharmaceuticals, Inc.（INDV）财务数据对比。点击上方公司名可切换其他公司
Diversified Energy Co的季度营收约是Indivior Pharmaceuticals, Inc.的1.9倍（$666.5M vs $357.0M），Diversified Energy Co净利率更高（29.3% vs 28.9%，领先0.5%），Diversified Energy Co自由现金流更多（$280.0M vs $-245.0M）
DTE能源是一家总部位于底特律的综合能源企业，在美国与加拿大开展能源相关业务的开发与运营。公司业务板块涵盖电力与燃气公用事业，其中电力业务为密歇根州220万客户服务，燃气业务则服务于该州130万客户。
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
DEC vs INDV — 直观对比
营收规模更大
DEC
是对方的1.9倍
$357.0M
净利率更高
DEC
高出0.5%
28.9%
自由现金流更多
DEC
多$525.0M
$-245.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $666.5M | $357.0M |
| 净利润 | $195.5M | $103.0M |
| 毛利率 | — | 82.1% |
| 营业利润率 | 37.6% | 22.7% |
| 净利率 | 29.3% | 28.9% |
| 营收同比 | — | — |
| 净利润同比 | — | 390.5% |
| 每股收益（稀释后） | — | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DECINDV
| Q4 25 | $666.5M | $357.0M | ||
| Q3 25 | $499.8M | $314.0M | ||
| Q2 25 | $600.3M | $302.0M | ||
| Q1 25 | — | $266.0M | ||
| Q3 24 | — | $307.0M | ||
| Q2 24 | — | $299.0M |
净利润DECINDV
| Q4 25 | $195.5M | $103.0M | ||
| Q3 25 | $171.1M | $42.0M | ||
| Q2 25 | $297.7M | $18.0M | ||
| Q1 25 | — | $47.0M | ||
| Q3 24 | — | $22.0M | ||
| Q2 24 | — | $-97.0M |
毛利率DECINDV
| Q4 25 | — | 82.1% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | 44.7% | 82.8% | ||
| Q1 25 | — | 83.1% | ||
| Q3 24 | — | 78.5% | ||
| Q2 24 | — | 73.6% |
营业利润率DECINDV
| Q4 25 | 37.6% | 22.7% | ||
| Q3 25 | 36.2% | 13.7% | ||
| Q2 25 | 48.5% | 23.8% | ||
| Q1 25 | — | 24.8% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -39.5% |
净利率DECINDV
| Q4 25 | 29.3% | 28.9% | ||
| Q3 25 | 34.2% | 13.4% | ||
| Q2 25 | 49.6% | 6.0% | ||
| Q1 25 | — | 17.7% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | -32.4% |
每股收益（稀释后）DECINDV
| Q4 25 | — | $0.79 | ||
| Q3 25 | $2.14 | $0.33 | ||
| Q2 25 | $3.67 | $0.14 | ||
| Q1 25 | — | $0.38 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $-0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.7M | $195.0M |
| 总债务越低越好 | $2.7B | — |
| 股东权益账面价值 | $984.1M | $-98.0M |
| 总资产 | $6.2B | $1.2B |
| 负债/权益比越低杠杆越低 | 2.76× | — |
8季度趋势，按日历期对齐
现金及短期投资DECINDV
| Q4 25 | $29.7M | $195.0M | ||
| Q3 25 | — | $445.0M | ||
| Q2 25 | $23.7M | $510.0M | ||
| Q1 25 | — | $373.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务DECINDV
| Q4 25 | $2.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益DECINDV
| Q4 25 | $984.1M | $-98.0M | ||
| Q3 25 | — | $-207.0M | ||
| Q2 25 | $727.7M | $-257.0M | ||
| Q1 25 | — | $-285.0M | ||
| Q3 24 | — | $-310.0M | ||
| Q2 24 | — | $-281.0M |
总资产DECINDV
| Q4 25 | $6.2B | $1.2B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $5.7B | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
负债/权益比DECINDV
| Q4 25 | 2.76× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $464.6M | $-221.0M |
| 自由现金流经营现金流 - 资本支出 | $280.0M | $-245.0M |
| 自由现金流率自由现金流/营收 | 42.0% | -68.6% |
| 资本支出强度资本支出/营收 | 27.7% | 6.7% |
| 现金转化率经营现金流/净利润 | 2.38× | -2.15× |
| 过去12个月自由现金流最近4个季度 | — | $-93.0M |
8季度趋势，按日历期对齐
经营现金流DECINDV
| Q4 25 | $464.6M | $-221.0M | ||
| Q3 25 | — | $-39.0M | ||
| Q2 25 | $264.1M | $158.0M | ||
| Q1 25 | — | $75.0M | ||
| Q3 24 | — | $2.0M | ||
| Q2 24 | — | $88.0M |
自由现金流DECINDV
| Q4 25 | $280.0M | $-245.0M | ||
| Q3 25 | — | $-59.0M | ||
| Q2 25 | — | $141.0M | ||
| Q1 25 | — | $70.0M | ||
| Q3 24 | — | $-5.0M | ||
| Q2 24 | — | $84.0M |
自由现金流率DECINDV
| Q4 25 | 42.0% | -68.6% | ||
| Q3 25 | — | -18.8% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 26.3% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | 28.1% |
资本支出强度DECINDV
| Q4 25 | 27.7% | 6.7% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 1.9% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 1.3% |
现金转化率DECINDV
| Q4 25 | 2.38× | -2.15× | ||
| Q3 25 | — | -0.93× | ||
| Q2 25 | 0.89× | 8.78× | ||
| Q1 25 | — | 1.60× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DEC
暂无分部数据
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
